A股異動 | 提示風險仍強勢 容大感光(300576.SZ)再次漲停創新高
格隆匯2月18日丨容大感光(300576.SZ)今日再次強勢漲停創新高,錄得3連板漲停。報35.59元,暫成交5.43億元,最新總市值42.71億元。

因近日股價持續大漲,容大感光今日早間公告,公司股票交易價格連續2個交易日漲幅偏離值累計超過20%,屬於股價異常波動情況。經公司核查,除因新冠肺炎疫情尚未完全恢復產能的情況外,近期公司內外部經營環境未發生重大變化。
另外,鑑於目前光刻膠業務在公司主營業務中佔比較小,請廣大投資者注意投資風險。公司一直致力於PCB感光油墨、光刻膠及配套化學品、特種油墨等電子化學品的研發、生產和銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.